Top movers analysis one hour before the close of the markets on 2026-07-29: top gainers and losers in today's session.
Apimeds Pharmaceuticals US Inc APUS
$5.15
▲ +4.67%
(+$0.23)
🎈 Low Float
Open
$4.77
Prev Close
$4.92
Day Range
$4.15 – $6.15
52W Range
$4.15 – $403.10
Market Cap
$7.77M
Beta
1.42
EPS (TTM)
$-6.34
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2025-05-09 |
| Shares Out. | 1,510,000 |
| Website | apimedsus.com/ ↗ |
| Phone | 18009279800 |
| Employees | 7 |
| Net Income | -$35.1M |
| Free Cash Flow | -$11.0M |
| Total Assets | $141.2M |
| Total Liabilities | $14.7M |
| Equity | $126.5M |
About Apimeds Pharmaceuticals US Inc
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Apimeds Pharmaceuticals US Inc is a publicly traded company under the ticker symbol APUS on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.